Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295120
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-02-28
Brief Title:
The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark CAP-D
Sponsor:
Research Unit for General Practice in Aalborg
Organization:
Research Unit for General Practice in Aalborg
Study Overview
Official Title:
The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark an Open-Label Pragmatic Randomised Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAP-D
Brief Summary:
The aim of this randomised controlled trial is to identify the optimal treatment duration with phenoxymethylpenicillin for community-acquired pneumonia diagnosed in general practice
Eligible participants are adults 18 years presenting in general practice with symptoms of an acute LRTI ie acute illness 21 days usually with cough and minimum one other symptom such as dyspnea sputum production wheezing chest discomfort or fever in whom the GP finds it relevant to treat with antibiotics
Consenting patients who meet all the eligibility criteria will be randomised 11111 to either three four five six or seven days of treatment with phenoxymethylpenicillin 12 MIE four times daily
Eligible participants are adults 18 years presenting in general practice with symptoms of an acute LRTI ie acute illness 21 days usually with cough and minimum one other symptom such as dyspnea sputum production wheezing chest discomfort or fever in whom the GP finds it relevant to treat with antibiotics
Consenting patients who meet all the eligibility criteria will be randomised 11111 to either three four five six or seven days of treatment with phenoxymethylpenicillin 12 MIE four times daily
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None